6V7C
Human Arginase1 Complexed with Bicyclic Inhibitor Compound 3
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | CLSI BEAMLINE 08ID-1 |
Synchrotron site | CLSI |
Beamline | 08ID-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2017-05-15 |
Detector | MARMOSAIC 300 mm CCD |
Wavelength(s) | 1.0000 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 52.980, 281.380, 67.260 |
Unit cell angles | 90.00, 90.08, 90.00 |
Refinement procedure
Resolution | 35.840 - 1.800 |
R-factor | 0.218 |
Rwork | 0.216 |
R-free | 0.26400 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3gmz |
RMSD bond length | 0.010 |
RMSD bond angle | 1.060 |
Data reduction software | XDS |
Data scaling software | autoPROC |
Phasing software | BUSTER |
Refinement software | BUSTER (2.11.7) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 65.420 | 1.811 |
High resolution limit [Å] | 1.800 | 1.805 |
Rmerge | 0.110 | 0.510 |
Number of reflections | 169488 | 1767 |
<I/σ(I)> | 9.7 | |
Completeness [%] | 94.5 | |
Redundancy | 3.5 | |
CC(1/2) | 0.990 | 0.550 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 7 | 293 | 10% MMT (pH 7.0) 0.1 M ammonium formate, 16-22% PEG 8000 |